Ray Dalio's ZBH Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 31,228 shares of Zimmer Biomet Holdings, Inc. (ZBH) worth $2.81 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in ZBH, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 142,530 shares. Largest reduction occurred in Q1 2025, reducing 191,972 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Zimmer Biomet Holdings (ZBH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zimmer Biomet Holdings (ZBH) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +63,396 | Add 0.00% | 63,396 | $72.76 |
| Q3 2013 | -52,589 | Reduce 82.95% | 10,807 | $79.76 |
| Q4 2013 | -3,811 | Reduce 35.26% | 6,996 | $90.48 |
| Q1 2014 | -6,996 | Sold Out | 0 | $0.00 |
| Q4 2014 | +2,089 | New Buy | 2,089 | $110.10 |
| Q1 2015 | -2,089 | Sold Out | 0 | $0.00 |
| Q2 2015 | +15,067 | New Buy | 15,067 | $106.06 |
| Q3 2015 | +3,791 | Add 25.16% | 18,858 | $91.21 |
| Q4 2015 | -12,360 | Reduce 65.54% | 6,498 | $99.57 |
| Q1 2016 | -6,498 | Sold Out | 0 | $0.00 |
| Q4 2016 | +22,454 | New Buy | 22,454 | $100.20 |
| Q1 2017 | -22,454 | Sold Out | 0 | $0.00 |
| Q1 2020 | +6,546 | New Buy | 6,546 | $98.08 |
| Q2 2020 | -6,546 | Sold Out | 0 | $0.00 |
| Q3 2020 | +50,685 | New Buy | 50,685 | $132.17 |
| Q4 2020 | +60,025 | Add 118.43% | 110,710 | $149.60 |
| Q1 2021 | +18,701 | Add 16.89% | 129,411 | $155.42 |
| Q2 2021 | +90,550 | Add 69.97% | 219,961 | $156.14 |
| Q3 2021 | +6,441 | Add 2.93% | 226,402 | $142.10 |
| Q4 2021 | +44,978 | Add 19.87% | 271,380 | $123.34 |
| Q1 2022 | +142,530 | Add 52.52% | 413,910 | $127.90 |
| Q2 2022 | -20,154 | Reduce 4.87% | 393,756 | $105.06 |
| Q3 2022 | +7,223 | Add 1.83% | 400,979 | $104.55 |
| Q4 2022 | -84,479 | Reduce 21.07% | 316,500 | $127.50 |
| Q1 2023 | -22,930 | Reduce 7.24% | 293,570 | $129.20 |
| Q2 2023 | -39,390 | Reduce 13.42% | 254,180 | $145.60 |
| Q3 2023 | +41,353 | Add 16.27% | 295,533 | $112.22 |
| Q4 2023 | +23,634 | Add 8.00% | 319,167 | $121.70 |
| Q1 2024 | +35,736 | Add 11.20% | 354,903 | $131.98 |
| Q2 2024 | -3,328 | Reduce 0.94% | 351,575 | $108.53 |
| Q3 2024 | -170,948 | Reduce 48.62% | 180,627 | $107.95 |
| Q4 2024 | +19,866 | Add 11.00% | 200,493 | $105.63 |
| Q1 2025 | -191,972 | Reduce 95.75% | 8,521 | $113.18 |
| Q2 2025 | -1,960 | Reduce 23.00% | 6,561 | $91.21 |
| Q3 2025 | +5,988 | Add 91.27% | 12,549 | $98.50 |
| Q4 2025 | +18,679 | Add 148.85% | 31,228 | $89.92 |
Ray Dalio's Zimmer Biomet Holdings Investment FAQs
Ray Dalio first purchased Zimmer Biomet Holdings, Inc. (ZBH) in Q2 2013, acquiring 63,396 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Zimmer Biomet Holdings, Inc. (ZBH) for 36 quarters since Q2 2013.
Ray Dalio's largest addition to Zimmer Biomet Holdings, Inc. (ZBH) was in Q1 2022, adding 413,910 shares worth $52.94 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 31,228 shares of Zimmer Biomet Holdings, Inc. (ZBH), valued at approximately $2.81 M.
As of the Q4 2025 filing, Zimmer Biomet Holdings, Inc. (ZBH) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Zimmer Biomet Holdings, Inc. (ZBH) was 413,910 shares, as reported at the end of Q1 2022.